Nursesarena Forum

Welcome, Guest: Help / Recent Posts / Search / Login / Register

Stats: 4194 Members, 8267 topics. Date: October 21, 2020, 02:33:35 AM

WHO Welcomes The Use Of Dexamethasone In Treating Critically COVID-19 Patients - News - Nursesarena Forum

Nursesarena Forum / General Category / News / WHO Welcomes The Use Of Dexamethasone In Treating Critically COVID-19 Patients (1188) Views

Pages (1) (Print) (Go Down)

WHO Welcomes The Use Of Dexamethasone In Treating Critically COVID-19 Patients by katty : June 19, 2020, 12:25:30 PM
The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.

The benefit was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease.

“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”

Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers. It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries.

The researchers shared initial insights about the results of the trial with WHO, and we are looking forward to the full data analysis in the coming days. WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19.

Today’s news builds off the WHO Research & Development Blueprint meeting, which took place in Geneva in mid-February to accelerate health technologies for COVID-19, where further research into the use of steroids was highlighted as a priority. The findings reinforce the importance of large randomized control trials that produce actionable evidence. WHO will continue to work together with all partners to further develop lifesaving therapeutics and vaccines to tackle COVID-19 including under the umbrella of the Access to COVID-19 Tools Accelerator.

Source :

Pages (1)

Viewing this topic: 0 Members and 1 Guest

Ebola outbreak: Mali doctor dies after treating preacher

Started by Idowu Olabode

Replies: 0
Views: 2967
Last post November 21, 2014, 05:24:58 PM
by Idowu Olabode
Cost To Treat Ebola: $1 Million For Two Patients In The US

Started by Idowu Olabode

Replies: 0
Views: 1306
Last post November 21, 2014, 10:02:55 PM
by Idowu Olabode
Ghana: Mental patients, care-givers sensitised on Act

Started by Idowu Olabode

Replies: 0
Views: 1002
Last post December 18, 2014, 08:54:08 AM
by Idowu Olabode
Germany: Nurse admits killing 30 patients because he was 'bored'

Started by Idowu Olabode

Replies: 0
Views: 2011
Last post January 08, 2015, 08:03:47 PM
by Idowu Olabode
On World Cancer Day, UN says ‘goal must be equitableaccess for all patients, in

Started by katty

Replies: 0
Views: 1837
Last post February 05, 2015, 03:59:59 PM
by katty

(Go Up)

Nursesarena Forum - Copyright © 2014 - 2020 Developed By Martin Sunday. All rights reserved.
SMF 2.0.17 | SMF © 2019, Simple Machines
SMFAds for Free Forums

Disclaimer: Every Nursesarena Forum member is solely responsible for anything that he/she posts or uploads on Nursesarena Forum.